Valion Bio (VBIO) EPS (Diluted) (2021 - 2025)
Powered by 
Analysis
Valion Bio (VBIO) EPS (Diluted) (2021 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Valion Bio | 298,792.01 | -1.90 Mn | -45,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -70.32 |
| Jun 30, 2025 | -54.86 |
| Mar 31, 2025 | -63.13 |
| Dec 31, 2024 | -129.01 |
| Sep 30, 2024 | -5.78 |
| Jun 30, 2024 | -8.27 |
| Mar 31, 2024 | -25.23 |
| Dec 31, 2023 | -70.74 |
| Sep 30, 2023 | -36.98 |
| Jun 30, 2023 | -179.01 |
| Mar 31, 2023 | -262.89 |
| Dec 31, 2022 | -5.83 |
| Sep 30, 2022 | -6.68 |
| Jun 30, 2022 | -7.84 |
| Mar 31, 2022 | -5.76 |
| Dec 31, 2021 | -16.40 |
| Sep 30, 2021 | -11.92 |
| Jun 30, 2021 | -13.46 |
| Mar 31, 2021 | -14.52 |